ARTICLE | Company News
Centocor deal
November 8, 1993 8:00 AM UTC
Centocor Inc. (CNTO) CNTO and Wellcome plc finalized their previously announced agreement to develop and market CNTO's Panorex monoclonal antibody for colorectal cancer and six other MAbs. Wellcome w...